Immunoassay Instruments/Analyzers Market Size, Share, Growth and Industry Research Report to 2024
The global immunoassay instruments/analyzers market was valued at USD 14.7 billion in 2015 and is projected to grow at a CAGR of 5.11% over the forecast period.
(firmenpresse) - The global immunoassay instruments/analyzers market was valued at USD 14.7 billion in 2015 and is expected to reach a value of USD 23.3 billion by 2024. The prime factors driving the immunoassay analyzers market growth include constant introduction of advanced products. In addition, growing clinical applications for investigation and diagnosis of various chronic and related infectious diseases is expected to drive the growth of the immunoassay instruments market.
The industry is rapidly growing due to the constant introduction and adoption of automated as well as advanced techniques for laboratory instruments and analyzers in developed countries.
Rising prevalence of infectious diseases and chronic conditions, which require early diagnosis, prevention, and treatment, is one of the main factors boosting the demand for immunoassay analyzers and compact consumable products in the healthcare sector. In addition, industry is gaining speed with the launch of innovative products such as compact and portable ichroma II of Boditech Med, Inc., which is an FDA-approved fluorescence scanning instrument. Moreover, with the U.S. FDA approval of the iStat cardiac Troponin I test cartridge that uses enzyme-linked immunosorbant assay (ELISA) method, commercialization of such immunoassay products is also expected to increase significantly over the next few years.
In North America, the government authorities and private companies have significantly contributed toward development of technology, supported research funding, and helped in commercialization of immunoassay analyzers and associated instruments. For instance, in June 2016, Abbott diagnostic launched Architect i1000SR, an automated immunoassay instrument that works on the principle of chemiluminescence. Using this system, number of different assays can be performed in a very short time.
Further Key Findings from the Study Suggest:
mmunoassay analyzers in the region.
cancer and autoimmune diseases, thereby promoting the utilization of immunoassays in the region.
& Company; Diasorin S.p.A; Bio Rad Laboratories; and Siemen Healthcare GmbH. Introduction and adoption of automated systems and innovative designs is expected to intensify the competition by changing the industrial framework over the forecast period.
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales(at)grandviewresearch.com
For More Information: http://www.grandviewresearch.com
Datum: 30.07.2019 - 09:20 Uhr
Sprache: Deutsch
News-ID 1551082
Anzahl Zeichen: 3873
contact information:
Contact person:
Town:
San Francisco
Phone: 1-888-202-9519
Kategorie:
Healthcare & Medical
Typ of Press Release: Financial
type of sending: send
Date of sending: 30.07.2019
Anmerkungen:
Diese Pressemitteilung wurde bisher 465 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Immunoassay Instruments/Analyzers Market Size, Share, Growth and Industry Research Report to 2024
"
steht unter der journalistisch-redaktionellen Verantwortung von
Grand View Research, Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
